Literature DB >> 28436331

lep Expression and Its Role in Obesity and Type-2 Diabetes.

Muhammad Imran Qadir1, Zara Ahmed1.   

Abstract

Obesity is metabolic disorder that increases the risk of diabetes, heart disease, and other metabolic syndromes in human beings. One sign of diabetes is increased blood glucose levels in the body. Glucose levels increase due to problems with insulin secretion or insulin resistance. Maturity onset of diabetes of the young is more common in adults and occurs due to insulin resistance. Both diabetes and obesity are major problems that are responsible for the death of millions of individuals every year, worldwide. Leptin, a 164-KDa hormone that is secreted by white adipose tissue, is a product of the lep gene. Mutation in lep decreases leptin concentration and increases obesity and type-2 diabetes mellitus. Leptin has been shown to produce positive effects on hunger, energy expenditure, and behavior and is thus useful in the treatment of obesity and type-2 diabetes. Leptin controls appetite through its effect on the hypothalamus in the brain. Both leptin and insulin regulate appetite, body weight, and glucose levels in the body.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28436331     DOI: 10.1615/CritRevEukaryotGeneExpr.2017019386

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  7 in total

1.  Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study.

Authors:  Mohammad Muzaffar Mir; Rashid Mir; Mushabab Ayed Abdullah Alghamdi; Javed Iqbal Wani; Zia Ul Sabah; Mohammed Jeelani; Vijaya Marakala; Shahzada Khalid Sohail; Mohamed O'haj; Muffarah Hamid Alharthi; Mohannad Mohammad S Alamri
Journal:  J Pers Med       Date:  2022-05-01

2.  Adipokine Profile in Patients with Type 2 Diabetes Depends on Degree of Obesity.

Authors:  Joanna Kocot; Piotr Dziemidok; Małgorzata Kiełczykowska; Anna Hordyjewska; Grzegorz Szcześniak; Irena Musik
Journal:  Med Sci Monit       Date:  2017-10-19

3.  Transcriptional Profiling and Biological Pathway(s) Analysis of Type 2 Diabetes Mellitus in a Pakistani Population.

Authors:  Zarish Noreen; Christopher A Loffredo; Attya Bhatti; Jyothirmai J Simhadri; Gail Nunlee-Bland; Thomas Nnanabu; Peter John; Jahangir S Khan; Somiranjan Ghosh
Journal:  Int J Environ Res Public Health       Date:  2020-08-13       Impact factor: 3.390

4.  Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus: A population-based study.

Authors:  Wei Liu; Xianghai Zhou; Yufeng Li; Simin Zhang; Xiaoling Cai; Rui Zhang; Siqian Gong; Xueyao Han; Linong Ji
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.889

5.  Correlation of glycemic regulation and endotrophin in patients with type 2 Diabetes; pilot study.

Authors:  Sengul Aydin Yoldemir; Yucel Arman; Murat Akarsu; Ozgur Altun; Mustafa Ozcan; Tufan Tukek
Journal:  Diabetol Metab Syndr       Date:  2021-01-21       Impact factor: 3.320

Review 6.  Enhancer RNA (eRNA) in Human Diseases.

Authors:  Yunzhe Wang; Chenyang Zhang; Yuxiang Wang; Xiuping Liu; Zhao Zhang
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

7.  Screening of LEP gene polymorphisms as a risk factor for obesity and type 2 diabetes in Iraqis.

Authors:  Maysoon Khudheyer Almyah; Adnan Issa Albadran
Journal:  Mol Biol Res Commun       Date:  2019-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.